|
Nov 9
|
Emergent BioSolutions (EBS) Q3 2023 Earnings Call Transcript
|
|
Nov 8
|
Emergent BioSolutions Reports Third Quarter 2023 Financial Results
|
|
Oct 19
|
Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023
|
|
Oct 16
|
Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic
|
|
Oct 2
|
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
|
|
Aug 30
|
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
|
|
Aug 29
|
Oracle upgraded, Farfetch downgraded: Wall Street's top analyst calls
|
|
Aug 9
|
Emergent (EBS) Q2 Earnings Miss Estimates, Revenues Beat
|
|
Aug 9
|
Q2 2023 Emergent BioSolutions Inc Earnings Call
|
|
Aug 9
|
Emergent BioSolutions (EBS) Q2 2023 Earnings Call Transcript
|
|
Aug 8
|
Emergent Biosolutions (EBS) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 8
|
Emergent BioSolutions Reports Financial Results for Second Quarter 2023
|
|
Aug 8
|
Emergent BioSolutions to lay off 400 as its scales back its contract manufacturing business
|
|
Aug 8
|
UPDATE 1-Emergent BioSolutions to lay off about 400 employees
|
|
Aug 8
|
Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
|
|
Aug 7
|
Drug, Biotech Stocks' Q2 Earnings on Aug 8: LLY, LGND & More
|